Manufacturing news briefs – stories you might have missed
Starpharma’s loss, strong financial position Biotechnology company Starpharma‘s loss narrowed during FY24 by 48 percent from $15.6 million to $8.2 million. Net cash outflow of $11.8 million was down $7.4 million from FY23 on revenue up 132 percent to $9.8 million. Revenue included a one-time $6.6 million cash payment from Mundipharma on termination of a…
